Document Detail

A 10-year angiographic follow-up of competitive flow in sequential and composite arterial grafts.
MedLine Citation:
PMID:  21236696     Owner:  NLM     Status:  Publisher    
Objective: Physiological reaction to competitive flow is considered as the primary mechanism of arterial graft occlusion. Reopening of graft lumen had been also reported, but details remain unknown. We sought to delineate the effect of management of the moderately stenotic targets on the occurrence of competitive flow and clinical results. Methods: Clinical records and angiograms of 3263 bypass grafts in 852 patients, who underwent off-pump coronary revascularization using the internal thoracic artery (ITA) and radial artery without aortic manipulation since 2000, were examined. Dominant flow direction was graded as antegrade, competitive, and no flow (occlusion). Late angiography was performed in 157 patients with 561 bypass grafts for clinical reasons. The follow-up period was 55.5±31.1 months. Results: The early graft patency rate was 98.0% (3197/3263). The rate of antegrade flow was 91.5% (2986/3263), while competitive flow was detected in 6.5% (211/3263). The actuarial patency rates of bypass grafts with antegrade flow were significantly higher than those with competitive flow (87.9% at 5 years and 71.3% at 8 years, vs 25.8% at 5 years and 9.2% at 8 years, p<0.0001). In the univariate and multivariate analyses for 852 patients, territory of right coronary artery (odds ratio (OR)=2.20, p=0.0002), composite radial artery (OR=1.90, p=0.03), and the distal end of the graft (OR=2.90, p=0.0003), were identified as the significant predictors of competitive flow from the target with 51-75% stenosis. Individual grafting inversely correlated with occurrence of competitive flow (OR=0.48, p=0.04). Reopening of the graft lumen associated with progression of native stenosis was not observed in these patients. Conclusions: Competitive flow can be efficiently avoided by appropriate graft arrangement and patients' selection. Selection of the target of the graft end would be crucial to achieve antegrade bypass flow and long-term patency of entire sequential bypass grafts. For the composite graft, functional recovery of the occluded graft would be extremely rare.
Hiroyuki Nakajima; Junjiro Kobayashi; Koji Toda; Tomoyuki Fujita; Yusuke Shimahara; Yoichiro Kasahara; Soichiro Kitamura
Related Documents :
6349436 - Contagious equine metritis: distribution of organisms in experimental infection of mares.
18568986 - Placental pathology in trap sequence: clinical and pathogenetic implications.
16570186 - Estimation of cardiac output in a pharmacological trial using a simple method based on ...
3710286 - Effect of ethanol on human umbilical artery and vein in vitro.
22102786 - Prevalence of significant carotid artery stenosis in iranian patients with peripheral a...
17490356 - Ct06 aortic fat pad and new atrial fibrillation post cardiac surgery. cardiac lymphatic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-12
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  -     ISSN:  1873-734X     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aortic valve repair with ascending aortic aneurysms: associated lesions and adjunctive techniques.
Next Document:  The role of Toll-like receptor mediated signalling in the pathogenesis of multiple myeloma.